Vietnam reported first human infection with avian influenza H9N2 virus
On Apr. 12, 2024, the U.S. Centers for Disease Control and Prevention (CDC) announced that Vietnam had reported…
Study suggested staying current with COVID-19 vaccinations helped combat emerging variants
On Apr. 12, 2024, Oregon Health Sciences University (OHSU) announced research that shows using live SARS-CoV-2 virus revealed…
Labcorp received FDA Emergency Use Authorization for Mpox PCR test home collection kit
On Apr. 10, 2024, LabCorp announced that the U.S. Food and Drug Administration (FDA) had granted Emergency Use…
CDC reported human infection with highly pathogenic avian influenza A(H5N1) virus in Texas
On Apr. 5, 2024, the U.S. Centers for Disease Control and Prevention (CDC) announced that Texas had reported…
USDA confirmed highly pathogenic avian influenza USDA in dairy herd in Idaho
On Apr. 2, 2024, the U.S. Department of Agriculture (USDA) confirmed the detection of highly pathogenic avian influenza…
USDA confirmed highly pathogenic avian influenza USDA in dairy herd in New Mexico
On Apr. 1, 2024, the U.S. Department of Agriculture (USDA) confirmed the detection of highly pathogenic avian influenza…
Biotechnology | CDC | Diagnostics | Infectious Disease | Influenza | USDA | Vaccine | Veterinary
CDC reported first human infection in 2024 with an influenza virus from pigs
On Mar. 29, 2024, the U.S. Centers for Disease Control and Prevention (CDC) reported the first U.S. human…
Idaho Department of Agriculture reported avian influenza detected in Cassia County dairy herd
On Mar. 28, 2024, the Idaho State Department of Agriculture (ISDA) announced it had identified a highly pathogenic…
Roche received FDA approval for the first molecular test to screen for malaria in blood donors
On Mar. 26, 2024, Roche announced that the U.S. Food and Drug Administration (FDA) had approved the cobas…
USDA, HHS announced actions to reduce impact and spread of H5N1
On Mar. 25, 2024, immediately following the first detection of H5N1 in dairy cattle in the Texas panhandle…
FDA issued EUA for Pemgarda (pemivibart) for pre-exposure prophylaxis of COVID-19 in certain adults and adolescents
On Mar. 22, 2024, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization for Pemgarda…
Goat tested positive for same influenza virus affecting poultry in Stevens County, Minnesota
On Mar. 20, 2024, the Minnesota Board of Health announced that a Stevens County goat kid (juvenile goat)…
COVID reduced global life expectancy by 1.6 years
On Mar. 14, 2024, the Institute for Health Metrics and Evaluation (IHME) released all-cause mortality, life expectancy, and…
Biotechnology | CDC | FDA | Infectious Disease | Influenza | Vaccine
U.S. transitioning to trivalent flu vaccines for 2024-2025
On Mar. 8, 2024, the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee…
New antibodies target ‘Dark Side’ of influenza virus protein
On Mar. 1, 2024, researchers at the National Institutes of Health (NIH) announced they had identified antibodies targeting…
U.S. CDC Advisory Committee recommended use of Valneva’s single-dose Chikungunya caccine IXCHIQ
On Feb. 29, 2024, Valneva announced that the U.S. Centers for Disease Control and Preventionﾒs (CDC) Advisory Committee…
Novavax’s protein-based non-mRNA COVID-19 vaccine available as additional dose for individuals aged 65 and older
On Feb. 28, 2024, the U.S. Centers for Disease Control and Preventionﾒs (CDC) Advisory Committee on Immunization Practices…
USDA confirmed highly pathogenic avian influenza in backyard non-poultry flock in West Virginia
On Feb. 20, 2024, the U.S. Department of Agriculture (USDA) confirmed the presence of highly pathogenic avian influenza…
First human influenza A(H5N1) (bird flu)virus infections in Cambodia reported for 2024
On Feb. 12, 2024, the U.S. Centers for Disease Control and Prevention (CDC) announced that Cambodia had reported…
Alaska Department of Health confirmed first fatal case of Alaskapox virus
On Feb. 9, 2024, the state of Alaska Department of Health Alaska Department of Health confirmed the first…
Deschutes County confirmed case of human plague in local resident
On Feb. 8, 2024, Deschutes County Health Services in Bend, Oregon confirmed a case of human plague in…
Switching arms improved effectiveness of two-dose vaccinations, Oregon Health & Science University study suggested
On Feb. 6, 2024, Oregon Health & Science University (OHSU) announced research that revealed as much as a…
New COVID-19 sa-mRNA Results from CSL and Arcturus Therapeutics Demonstrated Longer Duration of Immunity Compared to Conventional COVID-19 mRNA Vaccine Booster
On Feb. 5, 2024, CSL and and Arcturus Therapeutics announced the results of a follow-up analysis of a…
New study highlighted importance of bird flu surveillance in live bird markets
On Jan. 31, 2024, a U.S. Centers for Disease Control and Prevention (CDC) co-authored study published in Influenza…
Agriculture | Disease | Infectious Disease | Influenza | WHO
Avian influenza A(H10N5) and influenza A(H3N2) coinfection reported in China
On Jan. 27, 2024, the National Health Commission of the People’s Republic of China notified the World Health…
Catastrophic mortality of elephant seals in Argentina Identified as outbreak of avian influenza
On Jan. 22, 2024, the University of California, Davis announced the first reported outbreak of high pathogenicity H5N1…
First polar bear died of avian flu
On Jan. 9, 2024, biologists in Alaska have confirmed the first case of a polar bear dying after…
France detected bird flu on vaccinated ducks farm
On Jan. 4, 2024, France announced it had detected bird flu on a duck farm in the Vendee…
Beyfortus approved in China for the prevention of RSV disease in infants
On Jan. 4, 2024, AstraZeneca Sanofi’s Beyfortus (nirsevimab), a long-acting monoclonal antibody, was approved in China for the…
CCSL and Arcturus Therapeutics’ ARCT-154 Demonstrated Non-Inferiority to Original Strain and Superior Immunogenicity to Omicron BA.4/5 Variant Compared to First-Generation mRNA Vaccine Booster
On Dec. 21, 2023, CSL and and Arcturus Therapeutics announced the results of a Phase 3 study showing…